glp 1 agonist uses GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes GLP-1 receptor agonists show promise

Additionally, GLP-1 promotes the growth and proliferation of pancreatic cells, inhibits glucagon secretion, and enhances glucose uptake in peripheral tissues, making it a crucial factor in maintaining blood glucose stability

There are currently four GLP-1 receptor agonists approved for use in United States and five approved for use in the European Union (Table 1): exenatide twice daily, liraglutide once daily, exenatide once weekly, albiglutide once weekly, and lixisenatide once daily (available in Europe)

Katole, N

Key Points Among 1,021 patients receiving warfarin, TTR decreased by 2.1% following GLP-1 RA initiation

J Acad Nutr Diet